跳至主要内容
临床试验/TCTR20230904002
TCTR20230904002招募中2 期

Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Randomized, placebo-controlled, double-blind study

Thammasat university0 个研究点目标入组 45 人开始时间: 2023年9月4日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Patients with irritable bowel syndrome defined by the Rome IV criteria

排除标准

  • 1. pregnancy, 2. breastfeeding, 3. fecal incontinence, 4. severe comorbidities (end-stage renal disease, Child-Pugh class C cirrhosis, acquired immunodeficiency syndrome, cancer, cerebrovascular disease, cardiovascular disease), 5. immunodeficiency disorders, 6. use of immunosuppressive drugs, 7. use of probiotics within 4 weeks prior to study entry, 8. use of IBS medication within 4 weeks prior to study entry

研究者

相似试验